Wordt geladen...
单中心181例广泛期小细胞肺癌的二线化疗及生存分析
BACKGROUND AND OBJECTIVE: Small cell lung cancer (SCLC) is the most malignant neuroendocrine tumor and sensitive to chemotherapy and radiotherapy. However, most patients who receive first-line chemotherapy will relapse within one to two years. Once recurrent, it indicates poor prognosis. Currently,...
Bewaard in:
| Gepubliceerd in: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
中国肺癌杂志编辑部
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000619/ https://ncbi.nlm.nih.gov/pubmed/24229622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2013.11.02 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|